Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | ZNF629 | Human | 1,2-dimethylhydrazine | increases expression | ISO | Zfp629 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of ZFP629 mRNA | CTD | PMID:22206623 | ZNF629 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Zfp629 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of ZFP629 mRNA | CTD | PMID:21570461 | ZNF629 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Zfp629 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ZFP629 mRNA | CTD | PMID:33387578 | ZNF629 | Human | 3,4-methylenedioxymethamphetamine | decreases expression | ISO | Zfp629 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of ZFP629 mRNA | CTD | PMID:26251327 | ZNF629 | Human | 3,4-methylenedioxymethamphetamine | increases methylation | ISO | Zfp629 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in increased methylation of ZFP629 promoter | CTD | PMID:26251327 | ZNF629 | Human | 4,4'-sulfonyldiphenol | affects methylation | ISO | Zfp629 (Mus musculus) | 6480464 | bisphenol S affects the methylation of ZFP629 gene | CTD | PMID:31683443 | ZNF629 | Human | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of ZNF629 mRNA | CTD | PMID:32763439 | ZNF629 | Human | benzo[a]pyrene | multiple interactions | ISO | Zfp629 (Mus musculus) | 6480464 | Benzo(a)pyrene promotes the reaction [AHR protein binds to ZFP629 promoter] | CTD | PMID:19654925 | ZNF629 | Human | benzo[a]pyrene | increases expression | ISO | Zfp629 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of ZFP629 mRNA | CTD | PMID:22228805 | ZNF629 | Human | benzo[e]pyrene | increases methylation | EXP | | 6480464 | benzo(e)pyrene results in increased methylation of ZNF629 promoter | CTD | PMID:30157460 | ZNF629 | Human | bisphenol A | decreases methylation | ISO | Zfp629 (Mus musculus) | 6480464 | bisphenol A results in decreased methylation of ZFP629 promoter | CTD | PMID:27312807 | ZNF629 | Human | bisphenol A | increases expression | ISO | Zfp629 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of ZFP629 mRNA and bisphenol A results in increased expression of ZNF629 mRNA | CTD | PMID:25181051 and PMID:30816183 | ZNF629 | Human | C60 fullerene | decreases expression | ISO | Zfp629 (Rattus norvegicus) | 6480464 | fullerene C60 results in decreased expression of ZFP629 mRNA | CTD | PMID:19167457 | ZNF629 | Human | carbon nanotube | decreases expression | ISO | Zfp629 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | ZNF629 | Human | cobalt dichloride | increases expression | ISO | Zfp629 (Rattus norvegicus) | 6480464 | cobaltous chloride results in increased expression of ZFP629 mRNA | CTD | PMID:24386269 | ZNF629 | Human | copper(II) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of ZNF629 mRNA | CTD | PMID:19549813 | ZNF629 | Human | crocidolite asbestos | affects expression | ISO | Zfp629 (Mus musculus) | 6480464 | Asbestos and Crocidolite affects the expression of ZFP629 mRNA | CTD | PMID:29279043 | ZNF629 | Human | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of ZNF629 mRNA | CTD | PMID:25562108 and PMID:27989131 | ZNF629 | Human | dicrotophos | increases expression | EXP | | 6480464 | dicrotophos results in increased expression of ZNF629 mRNA | CTD | PMID:28302478 | ZNF629 | Human | enzyme inhibitor | multiple interactions | EXP | | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of ZNF629 protein | CTD | PMID:23301498 | ZNF629 | Human | ethanol | affects splicing | ISO | Zfp629 (Mus musculus) | 6480464 | Ethanol affects the splicing of ZFP629 mRNA | CTD | PMID:30319688 | ZNF629 | Human | FR900359 | decreases phosphorylation | EXP | | 6480464 | FR900359 results in decreased phosphorylation of ZNF629 protein | CTD | PMID:37730182 | ZNF629 | Human | gentamycin | decreases expression | ISO | Zfp629 (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of ZFP629 mRNA | CTD | PMID:33387578 | ZNF629 | Human | hydrogen cyanide | decreases expression | ISO | Zfp629 (Mus musculus) | 6480464 | Hydrogen Cyanide results in decreased expression of ZFP629 mRNA | CTD | PMID:33914522 | ZNF629 | Human | iron dichloride | decreases expression | EXP | | 6480464 | ferrous chloride results in decreased expression of ZNF629 mRNA | CTD | PMID:35984750 | ZNF629 | Human | lead(0) | affects expression | EXP | | 6480464 | Lead affects the expression of ZNF629 mRNA | CTD | PMID:28903495 | ZNF629 | Human | leflunomide | decreases expression | EXP | | 6480464 | leflunomide results in decreased expression of ZNF629 mRNA | CTD | PMID:28988120 | ZNF629 | Human | methapyrilene | increases methylation | EXP | | 6480464 | Methapyrilene results in increased methylation of ZNF629 promoter | CTD | PMID:30157460 | ZNF629 | Human | perfluorohexanesulfonic acid | decreases expression | EXP | | 6480464 | perfluorohexanesulfonic acid results in decreased expression of ZNF629 mRNA | CTD | PMID:25812627 | ZNF629 | Human | perfluorononanoic acid | decreases expression | EXP | | 6480464 | perfluoro-n-nonanoic acid results in decreased expression of ZNF629 mRNA | CTD | PMID:25812627 | ZNF629 | Human | perfluorooctane-1-sulfonic acid | decreases expression | EXP | | 6480464 | perfluorooctane sulfonic acid results in decreased expression of ZNF629 mRNA | CTD | PMID:25812627 | ZNF629 | Human | perfluorooctanoic acid | decreases expression | EXP | | 6480464 | perfluorooctanoic acid results in decreased expression of ZNF629 mRNA | CTD | PMID:25812627 | ZNF629 | Human | pirinixic acid | increases expression | ISO | Zfp629 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of ZFP629 mRNA | CTD | PMID:20813756 | ZNF629 | Human | potassium cyanide | decreases expression | ISO | Zfp629 (Mus musculus) | 6480464 | Potassium Cyanide results in decreased expression of ZFP629 mRNA | CTD | PMID:33914522 | ZNF629 | Human | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of ZNF629 mRNA | CTD | PMID:38568856 | ZNF629 | Human | titanium dioxide | increases methylation | ISO | Zfp629 (Mus musculus) | 6480464 | titanium dioxide results in increased methylation of ZFP629 gene | CTD | PMID:35295148 | ZNF629 | Human | troglitazone | decreases expression | ISO | Zfp629 (Mus musculus) | 6480464 | troglitazone results in decreased expression of ZNF629 mRNA | CTD | PMID:28973697 | ZNF629 | Human | trovafloxacin | increases expression | ISO | Zfp629 (Mus musculus) | 6480464 | trovafloxacin results in increased expression of ZFP629 mRNA | CTD | PMID:35537566 | ZNF629 | Human | urethane | decreases expression | EXP | | 6480464 | Urethane results in decreased expression of ZNF629 mRNA | CTD | PMID:28818685 | ZNF629 | Human | valproic acid | increases methylation | EXP | | 6480464 | Valproic Acid results in increased methylation of ZNF629 gene | CTD | PMID:29154799 | ZNF629 | Human | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of ZNF629 mRNA | CTD | PMID:28001369 | ZNF629 | Human | zidovudine | multiple interactions | EXP | | 6480464 | [Zidovudine co-treated with IFNA1 protein] results in increased expression of ZNF629 mRNA | CTD | PMID:20370541 | |